Objective: To analyze the national and international scientific evidence available in the literature on types of judicialization of health lawsuits. Method: Integrative review, which selected primary studies in the PubMed, LILACS, Web of Science and Scopus databases, with the Descriptors: judicial decisions, health's judicialization, Saúde (in Portuguese), Health, and the keyword: Judicial Action. Results: 30 studies were selected. In Brazil, the majority were legal claims for medicines and the other for medical errors, requests for vaccines, supplies for diabetics, food compounds, surgical procedure, examinations, among others. In international studies, lawsuits were found for medication, benefit coverage and hospitalization for psychiatric treatment. Conclusion: It is evident that the most demanded type of lawsuit was access to the medication at an international level. It is still more noticeable the little discussion on this subject, demonstrating that judicialization of medicines can indicate a reality of Brazil. Descriptors: Health's Judicialization; Judicial Decisions; Health; Right to Health; Public Health Policy.
INTRODUCTION
The fact that the Constitution of the Federative Republic of Brazil of 1988 (1) , in its art. 196, describe that "health is the right of all and the duty of the State, guaranteed by social and economic policies aimed at reducing the risk of diseases, and universal and equal access to lawsuits and services for their promotion, protection and recovery", initiated a phenomenon that today is denominated "judicialization of health". This phenomenon is interpreted as the costing of medical procedures, medications, treatments, hospitalizations, orthoses and prostheses by judicial means.
In Brazil, judicialization of health began in the 1990s, with a high demand for lawsuits by the Judiciary to ensure that managers of public health services provided antiretroviral medications. For the organization and regulation of the distribution of these medicines, the Política Pública de Distribuição Gratuita de Medicamentos (Public Policy for the Free Distribution of Medicines) was established through Law 9313/1996, which ensured free and universal distribution of antiretroviral agents. It was hoped that, with the implementation of this law, there would be a decrease in judicial demands which did not occur (2, 3) . According to a study carried out by the Oswaldo Cruz Foundation -Fiocruz, "Judicialização da Política de Saúde nos Municípios Brasileiros: Um retrato nacional", a profile of the judicialization was presented in the city of São Paulo, following a pattern presented in the national survey, where 65% relating to medicinal products (4) . This issue is of great relevance to public administration, since the number of lawsuits that are filed with the Municipalities, States or the Federation to grant health treatment is high, resulting in one more expense to the public sector to effect such payments (5) . During the last decades, judicialization of health has grown in some Latin American countries, such as Colombia which, with the enactment of Law 100/1993, reformulated the health system with the objective of providing universal coverage (6) . In Colombia, 640,000 lawsuits were filed by patients between 1999 and 2008, one of the highest rates of judicialization of health. In Argentina, 72% of lawsuits are of individual demands for access to medicines (7) . This study was carried out in the expectation of understanding aspects related to the increase of lawsuits for access to health services in Brazil; and, with this, to identify measures or alternatives to be adopted to reduce these lawsuits, as well as to identify gaps in knowledge on the subject.
OBJECTIVE
This study aims to analyze the national and international scientific evidence available in the literature on types of judicialization of health lawsuits.
METHOD

Study design
It is an integrative review, a method that aims to gather and synthesize the published studies, allowing general conclusions on a specific theme, and explanation of knowledge gaps (8) .
Methodological framework and stages
Evidence Based Practice is the methodological framework adopted. The study involved the following steps: elaboration of the research question, literature search of primary studies, data extraction, critical evaluation of the included primary studies, analysis and synthesis of results, and synthesis of the knowledge evidenced (9) . For data extraction, authors prepared and used a tool consisting of items related to identification of the article, objective and main results that answered the integrative review's guiding question.
Criteria of inclusion and exclusion
The inclusion criteria were complete articles in Portuguese, English and/or Spanish, published between 2007 and 2017, available in full that addressed the theme "health lawsuits involving access to all types of health services". Theses, dissertations, chapter books, theoretical articles, letter to the editor were excluded from the sample of this study.
Articles were searched between 2007 and 2017 in order to find the most recent publications related to the application of legislation, legal conduct and repercussions on the health service.
4
th Stage: Critical evaluation of the included primary studies Analyzes were performed independently by two reviewers, and the synthesis of the studies was presented in Charts 1 and 2.
th Stage: Analysis and synthesis of results
A descriptive analysis of each study was carried out, presenting a synthesis of the main results of these studies in Charts 1 and 2.
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th Stage: Synthesis of the knowledge evidenced
To evaluate the studies regarding Levels of Evidence, the classification was used in seven levels, being considered as level 1 (stronger) the evidence from a systematic review or meta-analysis of randomized clinical trials; level 2, evidence from well-delineated randomized clinical trials; level 3, evidence from well-delineated clinical trials without randomization; level 4, evidence from welldelineated cohort and case-control studies; level 5, evidence from a systematic review of descriptive and qualitative studies; level 6, evidence from a single descriptive or qualitative study; and level 7 (weaker), evidence from expert opinion (10) .
RESULTS
In the first analysis of the 512 studies, after reading the title and abstract, articles that did not address lawsuits in health and duplicate articles were excluded (n=414). In the second analysis, through reading in full (n=98), 53 studies that did not portray the subject and 18 that were theoretical articles, book chapter, theses and dissertations were excluded. Three studies that did not appear in the selection by the databases were included through manual search, resulting in 30 articles selected for this study ( Figure 1 ).
The years with the greatest number of publications were 2012, 2013, 2014 and 2015 with four publications in each year and in 2016 five studies were published. Regarding the language, 24 were published in Brazilian Portuguese, four in English and two in Spanish. 
Brazil
To evaluate the claims, offering empirical evidence that myth counters prevail and claim the heterogeneity of the phenomenon of judicialization.
Most applicants are, in fact, poor and older individuals who do not live in major metropolitan areas. They also depend on the State to provide their legal representation and most of the requested medicines were already on government forms.
(12) Cabral, I.; Rezende, L.F. 
Análise das ações judiciais individuais para fornecimento de medicamentos em São João da Boa Vista
Brazil
To describe the relationships between prescriber, lawyer, and pharmaceutical industry in lawsuits against the State.
Among lawsuits of a single office, 43.6% had prescriptions from one doctor X for a medication from a specific laboratory and that same doctor was also the main prescriber of another medication, in which they were represented by two other offices. Of the 321 medications identified in lawsuits, 316 were present in the RENAME. 
To apply the methodological model developed in the analysis of the individual judicial demands for access to medicines in Paraná State.
Results showed that the sources used in the study were not enough to identify and quantify all variables proposed in their dimensions, especially some of the indicators of sociodemographic characteristics. 
Colombia
To evaluate the therapeutic rationality of prescriptions of medicines authorized by guardianship in patients affiliated to the General System of Social Security in Health.
In 75.5% of the cases, the medication was correlated with the diagnosis and 66% of the patients were exposed to risks of medication interactions. 
Brazil
To characterize lawsuits that requested medicines considering the economic profile of their impetrants.
Residents of wealthier regions were responsible for more frequent lawsuits. Lawsuit costs were four times higher in the richer regions compared to the poorer region. 
Análise da demanda de medicamentos para uso off label por meio de ações judiciais na Secretaria de Estado de Saúde de Minas Gerais
Rev de Direito Sanitário. 2013; v. 14, n. 1, p. 98-121.
Brazil
To investigate the occurrence of a medication court application for indications not approved by the Agência Nacional de Vigilância Sanitária (Brazilian National Sanitary Surveillance Agency) through lawsuits against Minas Gerais State in 2010.
212 applications for off-label medications were identified, of which 46% were not included in pharmaceutical assistance programs. 
To analyze the decisions of the legal system on access of the population to medicines in the Sistema Único de Saúde (Brazilian Unified Health) System by judicial means regarding decision criteria and possible political and economic pressures.
The Federal Constitution and medical prescription were identified as a decision criterion in lawsuits.
(30) Vieira, F.S.; Zucchi, P. To understand the phenomenon of the judicialization of access to public health in Mato Grosso State.
Distorções causadas pelas ações judiciais à política de medicamentos no Brasil
Population is more aware of their rights and requires it through judicial decisions. To analyze the practice of preventive medicine, with regard to vaccination, resulting from the intervention of the Judiciary.
110 cases were identified, 25 of which were about the supply of vaccines to specific individuals. They emphasized that they did not find lawsuits that sought to force the State to act in a preventive way. To be continued Lawsuits in health: an integrative review Batistella PMF, Aroni P, Fagundes AL, Haddad MCFL.
Twenty-seven studies were found in Brazil, where medication lawsuits were predominant (74%). Afterwards, there were studies (26%) that described requests for surgical procedures, hospitalization at the Intensive Care Unit, medical error, consultations and exams, home care, surgeries, food supplements, orthoses and prostheses, hospitalization for psychiatric treatment, SPA hospitalization, request for vaccines, supplies for diabetics, home hospitalization, demand for hospital transportation, among others.
In international studies, lawsuits were found for medications in Colombia (n=1), benefit coverage in Argentina (n=1) and hospitalization for psychiatric treatment in Spain (n=1).
Synthesis of studies were categorized into lawsuits requiring medication (Chart 1) and lawsuits for surgical procedures, hospitalization at the Intensive Care Unit, medical error, consultations and examinations, surgical materials, home hospitalization, among others (Chart 2). Synthesis of studies is presented in the Charts in alphabetical order of authors.
DISCUSSION
The public health system in Brazil comprises a set of lawsuits and services, however, it is noted that most of the studies published on the types of judicialization of health lawsuits deal with access to medicines.
Lawsuits for medicines have been taking place even after the creation in 1996 of public policy, which promises the free and universal dispensation of medications. From this perspective, it is worth mentioning that lawsuits also occur with medications contained in the Relação Nacional de Medicamentos Essenciais (RENAME -National Relation of Essential Medicines). This practice needs to be reviewed in light of the fact that most of lawsuits are accompanied by a medical professionals' (3) . In this sense, 21 articles involved access to medications , in which six articles were required medications, such as Adalimumab and Etanercept (14`15`17`18`20`22) , indicated for the treatment To know the origin, the motive, the object, the plaintiff subject and the resolution of the judicial decisions.
Lawsuits were mostly requests for food compounds from glycemic control tapes. All medical prescriptions requested for trademarks and pediatric food allergy was the main reason for the lawsuit. (14`17`20`22) , also recommended for rheumatoid arthritis. Rituximab (16`22`25`28) was indicated for treatment of nonHodgkin's lymphoma. These medicines are present in RENAME, but the population has been finding difficulties in accessing these medicines, in which the pharmaceutical assistance policy presents flaws in the programming, acquisition and distribution of medications (18) . On the other hand, requests for non-standard and high-cost medications can be influenced by the pharmaceutical industry in partnership with prescribing doctors. And the irrational and unnecessary use of new medications, often without scientific evidence, aiming at the future standardization of this technology, and may be a factor that promotes an increase in the demand for medicines and high expenses with judicialization (41) . In order to standardize a new medication, it is necessary, in addition to the safety factors, effectiveness and effectiveness, that these are the best option in relation to the cost, because thus more people would have access (42) . Judicialization of health does not only include access to medicines. One of the articles found in this review refers to civil and criminal cases on medical error, in which the specialty with the greatest number of cases was Gynecology/Obstetrics (34) . Braga, Vieira and Martins (43) performed a study in which there was a tendency to increase lawsuits in the ophthalmological area, and a predominance of lawsuits in surgical ophthalmologic procedures.
In a recent study in the United States, medical errors are classified as the third leading cause of death, where data on mortality in the country were analyzed for eight years, noting that more than 250,000 deaths per year are attributed to errors (44) . However, the study detected little scientific publication on the judicialization of medical error.
It is noteworthy that the types of lawsuits outside Brazil were demands on coverage of benefits in Argentina, medicines, such as antiepileptics in Colombia and hospitalization for psychiatric treatment in Spain. Given the lack of world literature on the proposed theme, it is questioned whether health judicialization is a specific problem of greater transparency in Brazilian public health, or if the scarce publication is due to scientific omission, considering that nations worldwide are subject to such structuralpolitical complications.
Study limitations
The limitation of this study was that the selected databases were only those accessible to researchers of this study, and the extension of the search in other paid databases could contemplate other types of studies in other realities.
Contributions for the area of Public Policy
The study contributes to the characterization of health judicial demands, enabling public managers to detect failures in distribution and acquisition of medicines, which can avoid lawsuits for standardized medications. On the other hand, the study boosts reflection on the scientific evidence of requests before lawsuits are judged through consultations with doctors, in order to avoid prescriptions of non-standardized technologies, especially in medicines, and can thus reduce the quantity of lawsuits in health.
CONCLUSION
This integrative review found that access to the medication was the most obvious type of lawsuit. However, even with the increase in judicialization of health, what resulted in the main limitation of this study was the scarcity of literature on the subject. At the international level, the lack of discussion on the subject was even more evident, revealing that the judicialization of access to medicines may indicate a reality that is characteristic of Brazil. Thus, it is evident the need to produce new studies on the reason for requesting standardized medications through lawsuits. This indicates possible management failures in the acquisition and distribution of these medications and the reason for the medical prescription of non-standard medications, which may indicate a presumed lack of knowledge of prescribers about medications present in the SUS lists. This fact can also indicate the induction of prescription by the pharmaceutical industry, aiming at the inclusion of new medications.
